05:31 PM EST, 02/17/2026 (MT Newswires) -- Beta Bionics ( BBNX ) reported a Q4 loss late Tuesday of $0.30 per diluted share, narrowing from a loss of $2.72 a year earlier.

Analysts polled by FactSet expected a loss of $0.40.

Revenue for the three months ended Dec. 31 rose to $32.1 million from $20.4 million a year earlier.

Analysts surveyed by FactSet expected $30.4 million.

The company expects full-year 2026 revenue of $130 million to $135 million. Analysts expect $132.7 million.